# Sekisui Medical Co., Ltd., Hachimantai, Japan – FDA Inspections

Source: https://www.keypedia.com/companies/sekisui-medical-co-ltd/4dfadeea-0d4e-4543-9dfe-d210f0a51125

> Inspection records and compliance data for Sekisui Medical Co., Ltd. in Hachimantai. 5 FDA inspections on record (1 OAI), 1 Form 483, last inspected November 21, 2025.

---

## Details

- Name: Sekisui Medical Co., Ltd.
- FEI Number: 3002806840
- Facility Type: API Manufacturer
- Business Operations: API MANUFACTURE
- Address Line 1: Dai 4 Chiwari 115, Matsuo
- City: Hachimantai
- Country Name: Japan
- Address: Dai 4 Chiwari 115, Matsuo, Hachimantai, Japan
- Country: Japan

## Related Documents

- [483 - Sekisui Medical Co., Ltd. - 2025-11-21](https://www.keypedia.com/records/483/sekisui-medical-co-ltd/d60fd39c-26e5-4382-a570-6770401a164d) — source: FDA, date: November 21, 2025
- [FDA Inspection 1297890 - Sekisui Medical Co., Ltd. - 2025-11-21](https://www.keypedia.com/records/fda_inspections/sekisui-medical-co-ltd/5ac13948-1c7a-4e09-bca4-422b87205848) — source: FDA, date: November 21, 2025
- FDA Inspection 1297890 - Sekisui Medical Co., Ltd. - 2025-11-21 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 21, 2025
- FDA Inspection 1085997 - Sekisui Medical Co., Ltd. - 2019-03-08 — classification: No Action Indicated (NAI), source: FDA, date: March 8, 2019
- FDA Inspection 1025783 - Sekisui Medical Co., Ltd. - 2017-07-27 — classification: No Action Indicated (NAI), source: FDA, date: July 27, 2017
- [483 - Sekisui Medical Co., Ltd. - 2016-06-17](https://www.keypedia.com/records/483/sekisui-medical-co-ltd/8163dc62-7f2b-448a-a486-963443a0f62b) — source: FDA, date: June 17, 2016
- [FDA Inspection 975168 - Sekisui Medical Co., Ltd. - 2016-06-17](https://www.keypedia.com/records/fda_inspections/sekisui-medical-co-ltd/3873a59b-29f3-4fdc-ae08-7f96f6942a4d) — classification: Official Action Indicated (OAI), source: FDA, date: June 17, 2016
- FDA Inspection 754938 - Sekisui Medical Co., Ltd. - 2011-10-27 — classification: No Action Indicated (NAI), source: FDA, date: October 27, 2011

## Related Companies

- [Elementis SRL, Inc.](https://www.keypedia.com/companies/elementis-srl-inc/a0e92600-0839-472d-a886-90c12e51cacf)
- [GE Healthcare AS, Lindesnes Site](https://www.keypedia.com/companies/ge-healthcare-as-lindesnes-site/03ef9999-6a2c-4a7d-87be-cad66c893639)
- [ST Pharm Co., Ltd.](https://www.keypedia.com/companies/st-pharm-co-ltd/fd6521e7-0d83-45a3-ade6-ca4832858cbe)
- [Dr. Reddy's Laboratories Ltd](https://www.keypedia.com/companies/dr-reddys-laboratories-ltd/d2b12af8-d5d5-41a8-bb7a-b1acef5c5aa2)
- [Elementis Specialties (India) Private Limited](https://www.keypedia.com/companies/elementis-specialties-india-private-limited/1c638e07-22cd-495f-a398-96269847dbf2)
- [Dr. Reddy's Laboratories Limited (Unit II)](https://www.keypedia.com/companies/dr-reddys-laboratories-limited-unit-ii/8017cea4-be8d-4551-8eb7-f0f8cf4509da)
- [Dr. Reddy's Laboratories (EU) Ltd.](https://www.keypedia.com/companies/dr-reddys-laboratories-eu-ltd/c328d057-03f2-4963-b5fc-12e55c201be0)
- [Dr. Reddy's Laboratories Limited (Chemical Tech Ops - III)](https://www.keypedia.com/companies/dr-reddys-laboratories-limited-chemical-tech-ops-iii/f6d8f5e1-4852-4b4c-97da-6a29aaefc1b1)
- [Gland Pharma Limited](https://www.keypedia.com/companies/gland-pharma-limited/2bdef9e1-be40-4167-95c8-f08cba22365c)
- [Dr. Reddy's Laboratories Ltd, CTO Unit 1](https://www.keypedia.com/companies/dr-reddys-laboratories-ltd-cto-unit-1/6b22d2c7-7fa8-4df8-903f-4775c508dc57)

## Related Officers

- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [Pharmacist | Consumer Safety Officer](https://www.keypedia.com/people/victoria-spivak/b43d066f-35c1-4d83-9d38-3ba64d77cf31)
- [FDA_PERSONNEL](https://www.keypedia.com/people/mr-kouya-takimoto/a72d7f3a-a4f7-4e89-b7b4-ef08907b754d)